摘要
人类Hole(hHole)基因编码着有着319个氨基酸的6-跨膜蛋白。我们以往的研究表明,hHole在成人心脏中强烈表达,可以抑制细胞外信号调节激酶(ERK),过度激活会导致病理性心肌肥厚。在这项研究中,观察到在小鼠肥厚性心脏中Hole基因表达上调。在心脏特异性转基因小鼠模型中,观察到Hole基因特异性在心脏过度表达可以抑制异丙肾上腺素(ISO)引起的心肌肥厚和纤维化,钝化的ERK1/2、总的ERK1/2蛋白和磷酸化ERK1/2(ERK1/2)转录水平。此外,水尾静脉注射hHole质粒的小鼠hhole基因过表达也能抑制ISO诱导的心肌肥大。我们的工作确定了hHole基因作为一种新型的心肌肥厚的抑制剂,并提供了为心脏疾病的预防和治疗可能目标的新的见解。
关键词: 心肌肥厚;人Hole基因(hHole);异丙肾上腺素(ISO);细胞外信号调节激酶(ERK)。
Current Molecular Medicine
Title:Cardiac Specific Overexpression of hHole Attenuates Isoproterenol–Induced Hypertrophic Remodeling through Inhibition of Extracellular Signal-Regulated Kinases (ERKs) Signalling
Volume: 16 Issue: 5
Author(s): W. Xu, Y. Wang, J. Zhou, X. Zhu, S. Zhang, W. Yuan, X. Liu, Y. Shi, L. Cao, Q. Zeng, Z. Jiang, X. Ye, Y. Wan, X. Peng, Y. Deng and F. Chen, X. Wang, G. Dai, S. Luo, X. Fan, X. Mo, X. Wu, Y. Li
Affiliation:
关键词: 心肌肥厚;人Hole基因(hHole);异丙肾上腺素(ISO);细胞外信号调节激酶(ERK)。
摘要: The human Hole gene (hHole) encodes a six-transmembrane protein with 319- amino acids. Our previous study showed that hHole was strongly expressed in adult heart and may act as a suppressor of extracellular signal-regulated kinases (ERKs), overactivation of which contributed to pathological cardiac hypertrophy. In this study, it was observed that Hole expression was up-regulated in murine hypertrophic hearts. In a cardiac specific transgenic mouse model, it was observed that overexpression of hHole specifically in heart attenuated cardiac hypertrophy and fibrosis induced by isoproterenol (ISO), with blunted transcriptions of ERK1/2, total ERK1/2 proteins and phosphorylated ERK1/2 (p-ERK1/2) levels. Furthermore, overexpression of hHole in mice by hydrodynamic tail-vein injection with hHole plamids also inhibited cardiac hypertrophy induced by ISO. Our work identified hHole as a novel repressor of cardiac hypertrophy, and provided new insights into the possible target for the prevention or treatment of cardiac diseases.
Export Options
About this article
Cite this article as:
W. Xu, Y. Wang, J. Zhou, X. Zhu, S. Zhang, W. Yuan, X. Liu, Y. Shi, L. Cao, Q. Zeng, Z. Jiang, X. Ye, Y. Wan, X. Peng, Y. Deng and F. Chen, X. Wang, G. Dai, S. Luo, X. Fan, X. Mo, X. Wu, Y. Li , Cardiac Specific Overexpression of hHole Attenuates Isoproterenol–Induced Hypertrophic Remodeling through Inhibition of Extracellular Signal-Regulated Kinases (ERKs) Signalling, Current Molecular Medicine 2016; 16 (5) . https://dx.doi.org/10.2174/1566524016666160523143704
DOI https://dx.doi.org/10.2174/1566524016666160523143704 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Supplementation of Creatine and Ribose Prevents Apoptosis and Right Ventricle Hypertrophy in Hypoxic Hearts
Current Pharmaceutical Design Selenium Deficiency in Soils and Crops and its Impact on Animal and Human Health
Current Nutrition & Food Science Susceptibility Risk Alleles of -238G/A, -308G/A and -1031T/C Promoter Polymorphisms of TNF-α Gene to Uterine Leiomyomas
Recent Advances in DNA & Gene Sequences (Discontinued) Mitochondrial Dysfunction and Endoplasmic Reticulum Stress in Diabetes
Current Pharmaceutical Design NAD<sup>+</sup>/NADH Metabolism and NAD<sup>+</sup>-Dependent Enzymes in Cell Death and Ischemic Brain Injury: Current Advances and Therapeutic Implications
Current Medicinal Chemistry Isosteviol Protects H9c2 Cells Against Hypoxia-reoxygenation by Activating ERK1/2
Cardiovascular & Hematological Disorders-Drug Targets The ACE2-Ang-(1-7)-Mas Axis and Cardioprotection
Current Cardiology Reviews Gender Disparities on Access to Care and Coronary Disease Management
Current Pharmaceutical Design Chronic Heart Failure- Potential for Pharmacological Intervention
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Updates on HCN Channels in the Heart: Function, Dysfunction and Pharmacology
Current Drug Targets Closed-loop Neuropharmacology for Epilepsy: Distant Dream or Future Reality?
Current Neuropharmacology The Role of microRNA-126 in Vascular Homeostasis
Current Vascular Pharmacology Anderson-Fabry Disease: A Multiorgan Disease
Current Pharmaceutical Design Ryanodine Receptor as Insecticide Target
Current Pharmaceutical Design Atrial Remodeling and Novel Pharmacological Strategies for Antiarrhythmic Therapy in Atrial Fibrillation
Current Medicinal Chemistry Shutting Down the Furnace: Preferential Killing of Cancer Cells with Mitochondrial-Targeting Molecules
Current Medicinal Chemistry Sympathetic Overactivity in Hypertension and Cardiovascular Disease
Current Vascular Pharmacology Matrix Metallopropteinases in Heart Failure
Current Topics in Medicinal Chemistry Targeting Resveratrol to Mitochondria for Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Remdesivir and Hydroxychloroquine: A Compassionate Use in Covid-19
Current Drug Targets